In this interview, Megan Falsetta, PhD addresses the prevalence and characteristics of patients with vulvar disease. She discusses the role of inflammation in chronic vulvar pain. Dr. Falsetta highlights research findings indicating that exogenous specialized pro-resolving mediators (SPMs) have shown promising therapeutic effects in resolving pain in animal models. She expresses hope that SPMs might eventually help patients avoid invasive surgeries. Her team is planning to commence human trials soon. Dr. Falsetta concludes by discussing the role of Omega-3 supplements and nutrition in vulvar disease.
Megan Falsetta, PhD, is an Assistant Professor of Obstetrics and Gynecology, Pharmacology and Physiology at University of Rochester Medical Center.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
